Cargando…
Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta‐analyses
BACKGROUND: Tobacco smoking is the leading preventable cause of death and disease worldwide. Stopping smoking can reduce this harm and many people would like to stop. There are a number of medicines licenced to help people quit globally, and e‐cigarettes are used for this purpose in many countries....
Autores principales: | Lindson, Nicola, Theodoulou, Annika, Ordóñez-Mena, José M, Fanshawe, Thomas R, Sutton, Alex J, Livingstone-Banks, Jonathan, Hajizadeh, Anisa, Zhu, Sufen, Aveyard, Paul, Freeman, Suzanne C, Agrawal, Sanjay, Hartmann-Boyce, Jamie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495240/ https://www.ncbi.nlm.nih.gov/pubmed/37696529 http://dx.doi.org/10.1002/14651858.CD015226.pub2 |
Ejemplares similares
-
Antidepressants for smoking cessation
por: Hajizadeh, Anisa, et al.
Publicado: (2023) -
Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation
por: Theodoulou, Annika, et al.
Publicado: (2023) -
Nicotine receptor partial agonists for smoking cessation
por: Livingstone-Banks, Jonathan, et al.
Publicado: (2023) -
Nicotine receptor partial agonists for smoking cessation
por: Livingstone-Banks, Jonathan, et al.
Publicado: (2023) -
Biomarkers of potential harm in people switching from smoking tobacco to exclusive e‐cigarette use, dual use or abstinence: secondary analysis of Cochrane systematic review of trials of e‐cigarettes for smoking cessation
por: Hartmann‐Boyce, Jamie, et al.
Publicado: (2022)